Panel Discussion: New Political Landscape – How Will it Impact the Pharmaceutical Regulatory Environment?

Duration - 62 Minutes

Price - INR-2000 / USD-70
Book Now   Enquire Now  

About the course

  • The end of the Brexit transition period – Impact on pharmaceutical industry
  • What can pharmaceutical companies do right now to mitigate the risk?
  • Regulatory measures to respond better to issues of medicines shortages
  • Efficient and effective ways to prepare for remote interactions with regulatory authorities

Speaker Profile

Dr. Xavier Luria

Chief Executive Officer
Drug Development and Regulation

Martin FitzGerald

Deputy Director General
European Healthcare Distribution Association

Maria Manley

Partner and Head of UK Life Sciences
Sidley Austin LLP

Rita Purcell

Deputy Chief Executive
Health Products Regulatory Authority

Website by: Xpoteck